Bleeding disorders associated with cancer dysproteinemias.

Zangari, Maurizio; Elice, F; Tricot, G; Fink, L

Zangari, Maurizio; Elice, F; Tricot, G; Fink, L.

Affiliation

Zangari M; University of Utah, Division of Hematology, Blood/Marrow Transplant and Myeloma Program, Salt Lake City, UT, USA. maurizio.zangari@hsc.utah.edu

Cancer Treat Res ; 148: 295-304, 2009.

Article in En | MEDLINE | ID: mdl-19377931

Subject(s)

Hemorrhagic Disorders/etiology; Neoplasms/complications; Paraproteinemias/blood; Amyloidosis/blood; Amyloidosis/complications; Angiogenesis Inhibitors/therapeutic use; Animals; Blood Coagulation Factors/antagonists & inhibitors; Blood Coagulation Factors/physiology; Fibrinolysis; Hemorrhage/etiology; Hemorrhage/therapy; Hemorrhagic Disorders/blood; Hemorrhagic Disorders/therapy; Hemostatic Techniques; Humans; Neoplasms/blood; Paraproteinemias/etiology; Plasma Exchange; Rats; Thrombocytopenia/etiology; Waldenstrom Macroglobulinemia/blood; Waldenstrom Macroglobulinemia/complications

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paraproteinemias / Hemorrhagic Disorders / Neoplasms Type of study: Etiology_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Cancer Treat Res Year: 2009 Document type: Article

Fulltext

XML

PubMed Links

Search on Google